StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc. (GILD) operating KPIs

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)

Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%

Gilead Sciences gAAP operating margin (%) (%)

Form 8-K GAAP to Non-GAAP Reconciliation

QuarterlyAnnual
Latest, FY2025
34.0%
Period ended Dec 31, 2025
Change on a year earlier
+28.2 pts
5.8% in FY2024
History
10 years
Since FY2016
Sources
9
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedGAAP operating margin (%) (%)Year on yearSource
FY2025Dec 31, 202534.0%+28.2 ptsForm 8-K (exhibit991earningspressrel.htm, filed 2026-02-10) ↗
FY2024Dec 31, 20245.8%-22.2 ptsForm 8-K (exhibit991earningspressrel.htm, filed 2026-02-10) ↗
FY2023Dec 31, 202328.0%+1.1 ptsForm 8-K (exhibit991earningspressrel.htm, filed 2025-02-11) ↗
FY2022Dec 31, 202226.9%-9.4 ptsForm 8-K (exhibit991earningspressrel.htm, filed 2024-02-06) ↗
FY2021Dec 31, 202136.3%+19.8 ptsForm 8-K (exhibit991earningspressrel.htm, filed 2023-02-02) ↗
FY2020Dec 31, 202016.5%-2.6 ptsForm 8-K (exhibit991earningspressrel.htm, filed 2022-02-01) ↗
FY2019Dec 31, 201919.1%-18.0 ptsForm 8-K (exhibit991earningspressrel.htm, filed 2021-02-04) ↗
FY2018Dec 31, 201837.1%-17.0 ptsForm 8-K (exhibit991earningspres.htm, filed 2020-02-04) ↗
FY2017Dec 31, 201754.1%-3.9 ptsForm 8-K (exhibit991earningspressrel.htm, filed 2019-02-04) ↗
FY2016Dec 31, 201658.0%–Form 8-K (gildq42017exh991.htm, filed 2018-02-06) ↗

Cite this data

StockData. (2026). Gilead Sciences GAAP operating margin (%) (%), annual FY2016–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/gaap_op_margin_pct

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.